×

Edito

The endovascular treatment of critical limb ischemia (CLI) and diabetic foot has become an important and promising approach for revascularization of femoral, tibial and foot arteries, improving clinical outcomes and supporting limb salvage. The endovascular therapy for CLI is growing and evolving in terms of therapeutic indications, allowing us to improve our clinical daily practice in diabetic foot treatment and limb salvage.

This therapy is in continuing evolution, and directly related to new technical strategies and devices development. Learning and reviewing the basis, tips & tricks and mastering the techniques and therapeutic indications are essential to manage complex cases of diabetic CLI patients. Actually, most of endovascular specialists are interested in learning and treating this complex condition. For this reason we conceived this event, to support all this initiatives.

Our main objective in developing this conference is to gather experts from all around the world and our audience, to interact and share together, in a very friendly atmosphere. Based on a live-cases model, this event will focus on a step-by-step approach for each live procedure, supported by didactic discussions about decision making, technical strategies and therapies. The entire endovascular community dedicated to CLI will find in this conference the opportunity to fill the current gaps in the treatment of patients with Critical Limb Ischemia.
 

Program

March 23 - Morning

08.45 – 10.00 Live Case 1 (unconditioned sponsorship: Philips Volcano)

Operator: L.M. Palena - Chair: M. Manzi

10.30 – 12.00 Live Case 2 (unconditioned sponsorship: Bard)

Operator: L.M. Palena - Chair: M. Manzi
Panel: L. Diaz, R. Gandini, A. Schmidt, S. Thomas
 

March 23 - Afternoon

14.00 - 15.30 Live Case 3 (unconditioned sponsorship: Abbott Vascular)

Operator: M. Manzi - Chair: L.M. Palena
Panel: L. Diaz, R. Ferraresi, R. Gandini, A. Schmidt
 

16.00 – 17.30 Live Case 4 (unconditioned sponsorship: Asahi Intecc, Kardia)

Operator: M. Manzi - Chair: L.M. Palena
Panel: L. Diaz, M. Gargiulo, A. Schmidt, S. Thomas
 

March 24 - Morning

08.30 – 10.00 Live Case 5 (unconditioned sponsorship: Abbott Vascular)

Operator: M. Manzi - Chair: L.M. Palena
Panel: F. Fanelli, M. Gargiulo, A. Micari, A. Schmidt, S. Thomas
 

10.30 - 12.00 Live Case 6 (unconditioned sponsorship: Medtronic)

Operator: M. Manzi - Chair: L.M. Palena
Panel: L. Diaz, R. Ferraresi, M. Gargiulo, A. Micari
 

12.00 – 13.00 Lunch Symposium (click here to see video)

March 24 - Afternoon

13.00 - 14.30 Live Case 7 (unconditioned sponsorship: Bard)

Operator: L.M. Palena - Chair: M. Manzi
Panel: Y. Bausback, F. Fanelli, R. Ferraresi, S. Kum
 

15.00 - 16.30 Live Case 8 (unconditioned sponsorship: Boston Scientic)

Operator: L.M. Palena - Chair: M. Manzi
Panel: Y. Bausback, L. Diaz, R. Ferraresi, R. Gandini, S. Kum
 

 


Contributors

Larry Diaz-Sandoval , Wyoming, United states
Roberto Ferraresi , Bergamo, Milano, Italy
Yann Gouëffic , Nantes, France
Marco Manzi , Abano Terme, Italy
Luis Mariano Palena , Abano Terme, Italy
Shannon D. Thomas , Randwick, Australia
Pierfrancesco Veroux , Catania, Italy
March 2017
Honolulu : Friday, March 24th 2017 from 12:30am to 01:30am (GMT-10)
San Francisco : Friday, March 24th 2017 from 02:30am to 03:30am (GMT-8)
New York : Friday, March 24th 2017 from 05:30am to 06:30am (GMT-5)
Buenos Aires : Friday, March 24th 2017 from 07:30am to 08:30am (GMT-3)
London / Dublin : Friday, March 24th 2017 from 10:30am to 11:30am (GMT)
Paris / Berlin : Friday, March 24th 2017 from 11:30am to 12:30pm (GMT+1)
Istanbul : Friday, March 24th 2017 from 12:30pm to 01:30pm (GMT+2)
Moscou / Dubaï : Friday, March 24th 2017 from 02:30pm to 03:30pm (GMT+4)
Bangkok : Friday, March 24th 2017 from 05:30pm to 06:30pm (GMT+7)
Shanghai : Friday, March 24th 2017 from 06:30pm to 07:30pm (GMT+8)
Tokyo : Friday, March 24th 2017 from 07:30pm to 08:30pm (GMT+9)
Sydney : Friday, March 24th 2017 from 08:30pm to 09:30pm (GMT+10)
Wellington : Friday, March 24th 2017 from 10:30pm to 11:30pm (GMT+12)

New evidence for new generation stents

in Femoro-popliteal and BTK occlusions

Share
Scroll Up